Previous Close | 6.94 |
Open | 7.18 |
Bid | 4.74 x 200 |
Ask | 8.43 x 200 |
Day's Range | 6.51 - 7.18 |
52 Week Range | 3.54 - 7.75 |
Volume | |
Avg. Volume | 735,786 |
Market Cap | 163.271M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.06 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SINGAPORE, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for the development of mobile applications and SaaS subscription-based ISV Solutions, today announced the signing of an Investment Agreement with Evvo Labs Pte. Ltd. (“Evvo Labs”), an established and award-winning Cybersecurity company in Singapore. Investment and Collaboration Highlights: Orangekloud
Singapore, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for the development of mobile applications and SaaS subscription-based ISV Solutions, today announced the signing of a Memorandum of Understanding (MOU) with JPJ Medical (Pty) Ltd, a leading distributor of technology solutions within the medical and pharma sectors in South Africa, to form a strategic